By Nicole Weatherholtz | Thursday, 23 April 2026 07:05 PM EDT
Republicans in Congress are escalating their scrutiny of ActBlue, the major Democratic fundraising platform, by formally requesting its chief executive to testify on Capitol Hill.
House Administration Committee Chairman Bryan Steil, R-Wis., sent a letter Thursday inviting ActBlue CEO Regina Wallace-Jones to appear at a public hearing scheduled for May 19.
The request follows growing concerns among Republican lawmakers about how the organization manages political donations, particularly those potentially linked to foreign sources.
The move comes after a report indicated that ActBlue’s legal team had warned that CEO Wallace-Jones may have misled investigators reviewing the group’s safeguards on foreign contributions.
In his letter, Steil stated: “There are outstanding questions about whether and how ActBlue has remedied its ‘fundamentally unserious approach to fraud prevention.’ The Committee requests your prompt assistance in providing information vital to its oversight and investigatory duties.”
Steil also referenced “recent reporting” that suggested “ActBlue’s production of documents in response to the Committee’s July 2025 subpoena was deliberately incomplete.”
ActBlue and Wallace-Jones have denied any false statements were made to Congress, asserting that the organization has “cooperated fully and transparently” with investigators.
Democrats have dismissed the investigations—including a separate Justice Department inquiry—as politically motivated, arguing Republicans are targeting a key fundraising infrastructure for Democrats.
ActBlue’s legal counsel also raised concerns. In a Thursday letter addressed to Steil, House Judiciary Committee Chairman Jim Jordan, R-Ohio, and House Oversight Committee Chairman James Comer, R-Ky., attorney Vincent Cohen accused Republicans of shifting investigative demands to suit their political needs.
Cohen wrote: “While ActBlue remains committed to providing relevant information, it is deeply concerned that this latest action constitutes a continued partisan attack on a political opponent at a pivotal moment in the electoral cycle— and that Republican congressional leadership has singled out ActBlue not because of any alleged wrongdoing, but because Republicans see a political advantage to undermining the nonprofit that powers thousands of Democratic candidates and causes at every level.”
The recent outreach from Steil reflects House Republicans’ broader effort to expand their inquiry into ActBlue’s operations.
Last week, three GOP-led committees, including the House Administration Committee, pressed ActBlue for additional documents, alleging key materials had not been turned over.
Steil, Jordan and Comer wrote: “Given ActBlue’s demonstrated history of misleading Congress, there is considerable reason to believe that ActBlue may have deliberately withheld this responsive material to impede our investigation.”
